Recombinant multi-species HOGA1 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis
Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine HOGA1 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
The authors of PMID:20797690 cloned this gene while searching for genes in a region of chromosome 10 linked to primary hyperoxalurea type III. They noted that even though the encoded protein has been described as a mitochondrial dihydrodipicolinate synthase-like enzyme, it shares little homology with E. coli dihydrodipicolinate synthase (Dhdps), particularly in the putative substrate-binding region. Moreover, neither lysine biosynthesis nor sialic acid metabolism, for which Dhdps is responsible, occurs in vertebrate mitochondria. They propose that this gene encodes mitochondrial 4-hydroxyl-2-oxoglutarate aldolase (EC 4.1.3.16), which catalyzes the final step in the metabolic pathway of hydroxyproline, releasing glyoxylate and pyruvate. This gene is predominantly expressed in the liver and kidney, and mutations in this gene are found in patients with primary hyperoxalurea type III. Alternatively spliced transcript variants encoding different isoforms have been noted for this gene. [provided by RefSeq, Nov 2010]
The Alternative Names of target: 0610010D20Rik,4-hydroxy-2-oxoglutarate aldolase,C10orf65,DHDPS2,DHDPSL,Dhdpsl,Dihydrodipicolinate synthase-like (DHDPS-like protein),HOGA1,HP3,Hoga1,NPL2,Npl2,Probable 2-keto-4-hydroxyglutarate aldolase (Probable KHG-aldolase),Protein 569272,RGD1310475,mitochondrial
Go
to HOGA1 products collection
>>
(antibodies,
antigen, VLP, mRNA, ORF viral vector, etc)
Product information
| Catalog No. | Product Name | Species Reactivity |
|---|---|---|
| GM-Tg-hg-IP4099-Ag-1/ GM-Tg-hg-IP4099-Ag-2 | Human HOGA1 protein | Human |
| GM-Tg-rg-IP4099-Ag-1/ GM-Tg-rg-IP4099-Ag-2 | Rat HOGA1 protein | Rat |
| GM-Tg-mg-IP4099-Ag-1/ GM-Tg-mg-IP4099-Ag-2 | Mouse HOGA1 protein | Mouse |
| GM-Tg-cynog-IP4099-Ag-1/ GM-Tg-cynog-IP4099-Ag-2 | Cynomolgus/Rhesus macaque HOGA1 protein | Cynomolgus/ Rhesus macaque |
| GM-Tg-felg-IP4099-Ag-1/ GM-Tg-felg-IP4099-Ag-2 | Feline HOGA1 protein | Feline |
| GM-Tg-cang-IP4099-Ag-1/ GM-Tg-cang-IP4099-Ag-2 | Canine HOGA1 protein | Canine |
| GM-Tg-bovg-IP4099-Ag-1/ GM-Tg-bovg-IP4099-Ag-2 | Bovine HOGA1 protein | Bovine |
| GM-Tg-equg-IP4099-Ag-1/ GM-Tg-equg-IP4099-Ag-2 | Equine HOGA1 protein | Equine |
Size: 1mg | 10mg | 100mg
Product Description
| Catalog No. |
GM-Tg-hg-IP4099-Ag-1/ GM-Tg-hg-IP4099-Ag-2;
GM-Tg-rg-IP4099-Ag-1/ GM-Tg-rg-IP4099-Ag-2;
GM-Tg-mg-IP4099-Ag-1/ GM-Tg-mg-IP4099-Ag-2; GM-Tg-cynog-IP4099-Ag-1/ GM-Tg-cynog-IP4099-Ag-2; GM-Tg-felg-IP4099-Ag-1/ GM-Tg-felg-IP4099-Ag-2; GM-Tg-cang-IP4099-Ag-1/ GM-Tg-cang-IP4099-Ag-2; GM-Tg-bovg-IP4099-Ag-1/ GM-Tg-bovg-IP4099-Ag-2; GM-Tg-equg-IP4099-Ag-1/ GM-Tg-equg-IP4099-Ag-2 |
| Products Name | HOGA1 protein |
| Species | Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine |
| Target Name | HOGA1 |
| Protein Sub-location | Introcelluar Protein |
| Isotypes | Recombinant protein |
| Expression platform | Mammalian cell |
| Bioactivity validation | Affintiy&bioactivity validated by ELISA, cell culture validated. |
| Tag | His |
| Products description | Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine HOGA1 protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic). |
| Purity | Purity: ≥95% (SDS-PAGE) |
| Application | In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research. |
| Formulation & Reconstitution |
Lyophilized from GM's Protein Stability Buffer2
(PSB2,Confidential Ingredients) or PBS
(pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
| Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Reference
About Gmab

GMab, developed by GeneMedi, constitutes an
advanced library of recombinant
monoclonal antibodies, each meticulously
designed to target specific molecular
entities. Leveraging the sophisticated
capabilities of GM’s Taurus™ and LIBRA™
platforms, GMab synthesizes antibodies
characterized by high binding affinity,
exceptional physicochemical stability, and
optimal developability profiles.
Through
expression in mammalian cell lines, GMab has
been established as a paradigmatic
reference antibody. It holds significance in
myriad domains of biological drug
discovery, encompassing cellular cultivation,
innovative assay methodologies,
strategic animal model systematization, in-depth
pharmacokinetic & pharmacodynamic
(PK/PD) modeling, and intricate mechanism of
action (MOA) investigations.